Commission File Number 001-31914
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
December 17, 2020
China Life Insurance Company Limited
(Translation of registrants name into English)
16 Financial Street
Xicheng District
Beijing 100033, China
Tel: (86-10) 6363-3333
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
Yes ☐ No ☒
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-
Commission File Number 001-31914
On December 17, 2020, China Life Insurance Company Limited issued two announcements in Chinese, the English translations of which are attached as Exhibit 99.1 and Exhibit 99.2 hereto.
EXHIBIT LIST
Exhibit | Description | |
99.1 | English translation of the announcement, dated December 17, 2020 | |
99.2 | English translation of the announcement, dated December 17, 2020 |
Commission File Number 001-31914
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
China Life Insurance Company Limited | ||||||
(Registrant) | ||||||
By: | /s/ Su Hengxuan | |||||
(Signature) | ||||||
December 17, 2020 | Name: | Su Hengxuan | ||||
Title: | President and Executive Director |
EXHIBIT 99.1
Commission File Number 001-31914
中 國 人 壽 保 險 股 份 有 限 公 司
CHINA LIFE INSURANCE COMPANY LIMITED
(A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (the Company)
(Stock Code: 2628)
Announcement on the Resolutions of the Thirty-First Meeting of the Sixth Session of the Board of Directors of China Life Insurance Company Limited
The thirty-first meeting (the Meeting) of the sixth session of the Board of Directors (the Board) of China Life Insurance Company Limited (the Company) was held on December 17, 2020 in Beijing, Guangzhou, Hong Kong and San Francisco simultaneously by means of video conference. The directors were notified of the Meeting by way of a written notice dated December 3, 2020. Out of the Companys eleven directors, nine directors attended the Meeting. Su Hengxuan and Li Mingguang, executive directors of the Company, Liu Huimin, Yin Zhaojun and Wang Junhui, non-executive directors of the Company, and Chang Tso Tung, Stephen, Robinson Drake Pike, Tang Xin and Leung-Oi-Sie Elsie, independent non-executive directors of the Company, attended the Meeting. Wang Bin, chairman and executive director of the Company, was on leave for other business and authorized in writing, Su Hengxuan, executive director of the Company, to act on his behalf, cast the votes for him and preside over the Meeting. Yuan Changqing, non-executive director of the Company, was on leave for other business and authorized in writing, Li Mingguang, executive director of the Company, to act on his behalf and cast the votes for him. Supervisors and members of the management of the Company also attended the Meeting as non-voting delegates. The time, venue of the Meeting and the manner in which the Meeting was convened are in accordance with the Company Law of the Peoples Republic of China and the provisions under relevant laws, administrative regulations, departmental rules, Articles of Association and Rules of Procedures for the Board of Directors of the Company.
The Meeting was presided over by Su Hengxuan, executive director of the Company. The directors who attended the Meeting unanimously passed the following resolutions after sufficient review and discussion:
1. | The Proposal regarding Allocation Plan for the Companys Strategic Assets (Year 20212023) |
Voting result: 11 for, 0 against, with no abstention
2. | The Proposal regarding the Asset Allocation Plan of the Company (Year 2021) |
Voting result: 11 for, 0 against, with no abstention
3. | The Proposal regarding Compensation of Directors and Supervisors (Year 2019) |
The independent directors gave their independent opinions and agreed on the proposal. The Board of Directors agreed to submit the proposal to the general meeting of shareholders of the Company for approval. Please refer to a separate announcement filed by the Company on the same date for detailed information.
Commission File Number 001-31914
Voting result: 11 for, 0 against, with no abstention
4. | The Proposal regarding Compensation of Senior Management Members (Year 2019) |
The independent directors gave their independent opinions and agreed on the proposal. Please refer to a separate announcement filed by the Company on the same date for detailed information.
Voting result: 11 for, 0 against, with no abstention
5. | The Proposal regarding Results of Performance Evaluation of Senior Management Members (Year 2019) |
Voting result: 11 for, 0 against, with no abstention
6. | The Proposal regarding Remuneration Standards for Senior Management Members and other Personnel (Year 2020) |
Voting result: 11 for, 0 against, with no abstention
7. | The Proposal regarding the Administration Guidelines for Investment Entrusted by the Company to China Life Investment Holding Company Limited (Year 2021) |
Voting result: 11 for, 0 against, with no abstention
8. | The Proposal regarding the Authorization for Market-oriented Entrusted Investment for RMB Assets of the Company (Year 2021) |
Voting result: 11 for, 0 against, with no abstention
9. | The Proposal regarding the Authorization for the Companys Investment in Equity Investment Funds (Year 2021) |
Voting result: 11 for, 0 against, with no abstention
10. | The Proposal regarding the Authorization for the Companys Non-listed Equity Investment (Year 2021) |
Voting result: 11 for, 0 against, with no abstention
11. | The Proposal regarding the Authorization for the Companys Investment in Non-self-use Real Properties (Year 2021) |
Voting result: 11 for, 0 against, with no abstention
12. | The Proposal regarding the Authorization for the Companys Investment in Financial Products (Year 2021) |
Voting result: 11 for, 0 against, with no abstention
Commission File Number 001-31914
13. | The Proposal regarding the Companys Budget for Investment in Fixed Assets (Year 2021) |
Voting result: 11 for, 0 against, with no abstention
14. | The Proposal regarding the Plan of and Authorization for the Companys Investment in Self-use Real Properties (Year 2021) |
Voting result: 11 for, 0 against, with no abstention
15. | The Proposal on Amending the Entrusted Investment and Management Agreement for Investments with Insurance Funds between the Company and China Life Pension Company Limited |
This transaction constitutes a related party transaction under the rules of the China Banking and Insurance Regulatory Commission. Affiliated directors, including Wang Bin, Su Hengxuan, Yuan Changqing, Liu Huimin, Yin Zhaojun and Wang Junhui abstained from voting on this proposal. The independent directors gave their independent opinions and agreed on the proposal.
Voting result: 5 for, 0 against, with no abstention
16. | The Proposal on Executing the Insurance Sales Framework Agreement between the Company and China Life Property and Casualty Insurance Company Limited |
Affiliated directors, including Wang Bin, Su Hengxuan, Yuan Changqing, Liu Huimin, Yin Zhaojun and Wang Junhui abstained from voting on this proposal. The independent directors gave their independent opinions and agreed on the proposal. Please refer to a separate announcement filed by the Company on the same date for detailed information.
Voting result: 5 for, 0 against, with no abstention
17. | The Proposal on Renewal of the Policy Management Agreement between the Company and China Life Insurance (Group) Company |
Affiliated directors, including Wang Bin, Su Hengxuan, Yuan Changqing, Liu Huimin, Yin Zhaojun and Wang Junhui abstained from voting on this proposal. The independent directors gave their independent opinions and agreed on the proposal. Please refer to a separate announcement filed by the Company on the same date for detailed information.
Voting result: 5 for, 0 against, with no abstention
18. | The Proposal regarding Task Implementation and Assessment Results of the Company for Year 2019 |
Voting result: 11 for, 0 against, with no abstention
19. | The Proposal regarding Continuous Donation to China Life Charity Foundation |
Voting result: 11 for, 0 against, with no abstention
20. | The Proposal regarding Adoption of the Administrative Measures for Consumer Rights and Interests Protection of the Company (Trial Implementation) |
Commission File Number 001-31914
Voting result: 11 for, 0 against, with no abstention
21. | The Proposal regarding the Companys Fraud Risk Management Work Report for 2020 |
Voting result: 11 for, 0 against, with no abstention
22. | The Proposal regarding the Overall Risk Management Report of the Company for the Third Quarter of Year 2020 |
Voting result: 11 for, 0 against, with no abstention
For details of the proposals that the Board of Directors agreed to submit to the general meeting of shareholders of the Company for review and discussion, please refer to the notice of general meeting of shareholders and meeting materials that are to be separately published by the Company.
Board of Directors of China Life Insurance Company Limited
December 17, 2020
EXHIBIT 99.2
Commission File Number 001-31914
中 國 人 壽 保 險 股 份 有 限 公 司
CHINA LIFE INSURANCE COMPANY LIMITED
(A joint stock limited company incorporated in the Peoples Republic of China with limited liability)
(the Company)
(Stock Code: 2628)
Announcement on the Resolutions of the Fourteenth Meeting of the Sixth Session of the Board of Supervisors of China Life Insurance Company Limited
The fourteenth meeting (the Meeting) of the sixth session of the Board of Supervisors of the Company (the Board of Supervisors) was held on December 17, 2020 in Beijing. The supervisors were notified of the Meeting by way of a written notice dated December 10, 2020. All of the Companys four supervisors attended the Meeting. Jia Yuzeng, Chairperson of the Board of Supervisors, and Han Bing, Cao Qingyang and Wang Xiaoqing, supervisors of the Company, attended the Meeting in person. The time, venue and the manner in which the Meeting was convened are in accordance with the Company Law of the Peoples Republic of China and the provisions under relevant laws, administrative regulations, departmental rules, Articles of Association and Rules of Procedures for the Board of Supervisors of the Company.
The Meeting was presided over by Chairperson Jia Yuzeng. The supervisors who were present passed the following resolutions unanimously after sufficient review and discussion:
1. | The Proposal regarding the 2021 Work Plan of the Board of Supervisors of the Company |
Voting result: 4 for, 0 against, with no abstention
Board of Supervisors of China Life Insurance Company Limited
December 17, 2020